AKANTO v KANTOS - is suggestive character subject to proof?
The EU General Court has confirmed that there was a likelihood of confusion between Novartis AG’s mark AKANTO and Chiesi Farmaceutici SpA’s earlier mark KANTOS for goods in Class 5.
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the WTR experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10